Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
Direct to consumer pharmacy and formation as pharmacy benefit manager further mission to drastically expand access to affordable pharmaceuticals
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
_256_384.jpg)
Closing the Loop on single-use plastics
_256_384.jpg)
The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
The collaboration with Sanofi signifies a considerable investment in the UK’s Life Sciences sector and, along with other future strategic partners, has the potential to increase the pipeline of potential treatment options for a wide range of common and other life-threatening diseases
The six-layer packaging ensures that external media such as bacteria, light and air do not contaminate the liquid
Go-ahead for pivotal clinical trial which is expected to commence by March
Subscribe To Our Newsletter & Stay Updated
